McHale Duncan 4
4 · Evelo Biosciences, Inc. · Filed Jan 30, 2020
Insider Transaction Report
Form 4
McHale Duncan
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-28+117,000→ 117,000 totalExercise: $7.06Exp: 2030-01-27→ Common Stock (117,000 underlying)
Footnotes (1)
- [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of January 9, 2020, subject to continued employment on such dates.